Consolidated Balance Sheets - USD ($)	Sep. 30, 2019	Dec. 31, 2018
Current Assets
Cash and cash equivalents	$ 7,440	$ 1,477
Prepaid expenses	3,133	2,065
Total Current Assets	10,573	3,542
Intellectual property, net	208,958	222,071
TOTAL ASSETS	219,531	225,613
Current Liabilities
Accounts payable	10,722	6,304
Accrued expenses	4,472	350
Interest payable	46,216	40,232
Note payable	50,000	50,000
Convertible note	40,000	40,000
Loan from related party	681,044	627,044
Total Current Liabilities	832,454	763,930
TOTAL LIABILITIES	832,454	763,930
STOCKHOLDERS' DEFICIT
Preferred Stock: $0.0001 par value; 10,000,000 shares authorized; no shares outstanding at September 30, 2019, 500,000 shares issued and outstanding at December 31, 2018		50
Common Stock: $0.0001 par value; 200,000,000 shares authorized; 75,860,000 shares issued and outstanding at September 30, 2019 and 75,310,000 at December 31, 2018	7,586	7,531
Additional paid-in capital	1,626,268	1,616,273
Accumulated deficit	(2,246,777)	(2,162,171)
TOTAL STOCKHOLDERS' DEFICIT	(612,923)	(538,317)
TOTAL LIABILITIES & STOCKHOLDERS' DEFICIT	$ 219,531	$ 225,613